Rating History for Neurocrine Bio. (NBIX) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for NBIX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/2/2026 Corinne Johnson New Coverage Buy
(N/A)		 213.00
(N/A)		 161.00
(166.06)		 3.14% Details